Opinion|Videos|November 25, 2025

The Burden and Unmet Needs Associated with Desmoid Tumors

Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.

Panelists discuss the questions below in this video.

  • There any molecular biomarkers that are commonly associated with desmoid tumor?
  • What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo